REFERENCES
- Schaefer F, Bruttin O, Zografos L, Guex-Croisier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85:842–847.
- Chen FJ, Lo HJ. Molecular mechanism of fluoroquinolone resistance. J Microbiol Immunol Infect. 2003;36:1–9.
- Miller D, Flynn PM, Scott IU, et al. In vivo fluoroquinolone resistance in staphylococcical endophthalmitis isolate. Arch Opthalmol. 2006;124:479–483.
- Chalita MG, Hofeling-Limaq AL, Paranhos A, et al. Shifting trends in vitro antibiotics susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol. 2004;1:43–51.
- Yeh DL, Stinnet SS, Afshari AA. Analysis of bacterial cultures in infectious keratitis, 1997 to 2004. Am J Ophthalmol. 2006;142:1066–1068.
- National Commitee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. The National Committee for Clinical Laboratory Standards. 1993;13 (24):1–31.
- Everett SL, Kowalski RP, Karenchak LM, et al. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics. Cornea. 1995;14: 382–387.
- Osato MS, Jensen HG, Trousdale MD et al. The comparative in vitro activity of ofloxacin and selected antimicrobial agents against ocular bacteria isolates. Am J Ophthalmol. 1989;108: 380–386.
- Marangon FB, Miller D, Muallem MS et al. Ciprofloxacin and levoxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol. 2004;137: 453–458.
- Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis. Ophthalmology. 1999; 106:80–85.